Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Progenics Pharmaceuticals Inc (NASDAQ:PGNX)

6.01
Delayed Data
As of Jul 22
 -0.15 / -2.44%
Today’s Change
3.61
Today|||52-Week Range
11.15
-1.96%
Year-to-Date
3 Cheap Healthcare Stocks You Can Buy Right Now
Jul 21 / MotleyFool.com - Paid Partner Content
Valeant/Progenics Relistor Ok'd; FDA Panel Backs Brodalumab
Jul 20 / Zacks.com - Paid Partner Content
Progenics Pharmaceuticals (PGNX) Is Today's Perilous Reversal Stock
Jul 21 / TheStreet.com - Paid Partner Content
Heavy Early Morning Activity On Progenics Pharmaceuticals (PGNX)
Jul 20 / TheStreet.com - Paid Partner Content
4 Small-Cap Biotechs With Big Stories to Tell
Jul 21 / TheStreet.com - Paid Partner Content
Futures Point Downward for U.S. Markets as Asia Opens Lower
Jul 19 / TheStreet.com - Paid Partner Content
Why Progenics Pharmaceuticals, Inc. Shares Soared Today
Jul 20 / MotleyFool.com - Paid Partner Content
Progenics Pharmaceuticals (PGNX) Stock: Weak On High Volume Today
Jul 19 / TheStreet.com - Paid Partner Content
Progenics (PGNX) Stock Soars as Relistor Receives FDA Approval
Jul 20 / TheStreet.com - Paid Partner Content